MB

Michael Bauer

Partner at Novo Holdings

Copenhagen, Capital Region of Denmark

Overview

Work Experience

  • Member Board of Directors

    2024 - Current

  • Guest to the Board

    2023

  • Member Board of Directors

    2021

  • Partner

    2023

  • Venture Partner

    2020 - 2023

  • SVP Head of Operations R&D & Copenhagen Site Manager

    2018 - 2020

  • SVP Clinical Development & Copenhagen Site Manager

    2010 - 2017

  • SVP Clinical Development

    2010 - 2010

  • VP, Head of Development Project Management

    2009 - 2010

  • VP - US Development Operations

    2008 - 2008

  • Director - Project Management

    2006 - 2008

    Overall responsibility for two of Genmab,s Development projects

  • Associate

    2005 - 2006

    - Evaluation of clinical trial protocols and resulting data from BankInvest’s portfolio companies - Overview of established therapies per therapeutic area & market potential - Gold standards, medical need, treatment cost, market up-take - Project portfolio valuation of BankInvest’s portfolio companies; based on DCF/NPV calculations - Due Diligence in connection with new and follow-on investments; technology, clinical data, patents - Generation and implementation of re-structuring plans for one of BankInvest’s portfolio companies - Overview of Biotech / Pharma Industry landscape - M & A, licensing deals, therapeutic areas, product pipeline, development stage, clinical data

  • Associate - Scientific Licensing

    2004 - 2005

    - Identification and evaluation of new licensing opportunities within cancer inflammation - Leading of cross-functional evaluation teams - Science, strategic fit, IPR, market potential - Presenting results and recommendation to Discovery Management - Establishment of: - Strategic and collaborative alliances - In- and out licensing agreements - Agreements – Research, Consultancy and Material transfer - Participation in Discovery’s alliance implementation and management - Focus on contractual and relationship issues - Maintenance of agreements

  • Pharmacologist

    1998 - 2005

    - Design, implementation and evaluation of in vivo pharmacological studies to drive progress of discovery and early development projects - Establishment of state of the art disease models: - 1 year+ inflammation and cancer - 2 years+: obesity and type 2 diabetes - 2 years+: Growth Hormone physiology and reproduction - Initiation and monitoring of contract research projects - Scientific reporting internally and externally - Supervision and performance appraisal of reporting technical staff

  • Research Fellow & Associate Principle Scientist (RCDMB)

    1996 - 1998

  • Post Doc at Research Centre for Developmental Medicine & Biology (RCDMB)

    1992 - 1996

Relevant Websites